Inhibition of PKM2 blocked breast cancer progression and sensitized breast cancer cells to tamoxifen, indicating that PKM2 inhibitor may be an effective combination treatment in breast cancer patients treated with tamoxifen. Here, PKM is linked to breast cancer.